全身性重症肌无力-话题@MedSci

#全身性重症肌无力#

5篇内容 | 619人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1957386, encodeId=65c0195e38608, content=<a href='/topic/show?id=361f296867a' target=_blank style='color:#2F92EE;'>#全身性重症肌无力#</a>, objectTitle=JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较, objectType=article, longId=300333, objectId=438830033364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438830033364, replyNumber=0, likeNumber=50, createdTime=2023-01-08, rootId=0, userName=12498cb5m13暂无昵称, userId=838d2500169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438830033364, moduleTitle=JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=438830033364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957385, encodeId=6a1f195e385bb, content=<a href='/topic/show?id=361f296867a' target=_blank style='color:#2F92EE;'>#全身性重症肌无力#</a>, objectTitle=FDA 批准Vyvgart 治疗全身性重症肌无力, objectType=article, longId=292400, objectId=0146292400bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0146292400bd, replyNumber=0, likeNumber=33, createdTime=2022-10-24, rootId=0, userName=12498cb5m13暂无昵称, userId=838d2500169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0146292400bd, moduleTitle=FDA 批准Vyvgart 治疗全身性重症肌无力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0146292400bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957383, encodeId=1519195e3831c, content=<a href='/topic/show?id=361f296867a' target=_blank style='color:#2F92EE;'>#全身性重症肌无力#</a>, objectTitle=JAMA Neurol：Zillucoplan用于治疗中重度全身性重症肌无力, objectType=article, longId=188393, objectId=6b1e188393a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b1e188393a7, replyNumber=0, likeNumber=38, createdTime=2020-08-27, rootId=0, userName=12498cb5m13暂无昵称, userId=838d2500169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b1e188393a7, moduleTitle=JAMA Neurol：Zillucoplan用于治疗中重度全身性重症肌无力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b1e188393a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957384, encodeId=e2e1195e3842d, content=<a href='/topic/show?id=361f296867a' target=_blank style='color:#2F92EE;'>#全身性重症肌无力#</a>, objectTitle=JAMA Neurol：利妥昔单抗治疗新发全身性重症肌无力, objectType=article, longId=193615, objectId=8cad19361569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cad19361569, replyNumber=0, likeNumber=37, createdTime=2020-07-15, rootId=0, userName=12498cb5m13暂无昵称, userId=838d2500169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cad19361569, moduleTitle=JAMA Neurol：利妥昔单抗治疗新发全身性重症肌无力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cad19361569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957382, encodeId=e78b195e382bd, content=<a href='/topic/show?id=361f296867a' target=_blank style='color:#2F92EE;'>#全身性重症肌无力#</a>, objectTitle=Lancet Neurol：依库珠单抗治疗抗乙酰胆碱受体抗体阳性难治性全身性重症肌无力III期临床研究, objectType=article, longId=117236, objectId=41dc11e236e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41dc11e236e9, replyNumber=0, likeNumber=41, createdTime=2018-04-02, rootId=0, userName=12498cb5m13暂无昵称, userId=838d2500169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41dc11e236e9, moduleTitle=Lancet Neurol：依库珠单抗治疗抗乙酰胆碱受体抗体阳性难治性全身性重症肌无力III期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41dc11e236e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

全身性重症肌无力

2020-05-29

12498cb5m13暂无昵称 (审核中...)

前往app查看评论内容

#全身性重症肌无力#

JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较

2023-01-08

12498cb5m13暂无昵称 (审核中...)

前往app查看评论内容

#全身性重症肌无力#

FDA 批准Vyvgart 治疗全身性重症肌无力

2022-10-24

12498cb5m13暂无昵称 (审核中...)

前往app查看评论内容

#全身性重症肌无力#

JAMA Neurol：Zillucoplan用于治疗中重度全身性重症肌无力

2020-08-27

12498cb5m13暂无昵称 (审核中...)

前往app查看评论内容

#全身性重症肌无力#

JAMA Neurol：利妥昔单抗治疗新发全身性重症肌无力

2020-07-15

12498cb5m13暂无昵称 (审核中...)

前往app查看评论内容

#全身性重症肌无力#

Lancet Neurol：依库珠单抗治疗抗乙酰胆碱受体抗体阳性难治性全身性重症肌无力III期临床研究

2018-04-02

科室
- - 订阅+
  - 更多科室
工具
服务